Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL
- PMID: 29697929
- PMCID: PMC6092659
- DOI: 10.1590/S1677-5538.IBJU.2017.0506
Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL
Abstract
Purpose: To assess the accuracy of prostate-specific antigen (PSA) adjusted for the transition zone volume (PSATZ) in predicting prostate cancer by comparing the ability of several PSA parameters in predicting prostate cancer in men with intermediate PSA levels of 2.6 - 10.0 ng/mL and its ability to reduce unnecessary biopsies.
Materials and methods: This study included 656 patients referred for prostate biopsy who had a serum PSA of 2.6 - 10.0 ng/mL. Total prostate and transition zone volumes were measured by transrectal ultrasound using the prolate ellipsoid method. The clinical values of PSA, free-to-total (F/T) ratio, PSA density (PSAD) and PSATZ for the detection of prostate cancer were calculated and statistical comparisons between biopsy-positive (cancer) and biopsy-negative (benign) were conducted.
Results: Cancer was detected in 172 patients (26.2%). Mean PSA, PSATZ, PSAD and F/T ratio were 7.5 ng/mL, 0.68 ng/mL/cc. 0.25 ng/mL/cc and 0.14 in patients with prostate cancer and 6.29 ng/mL, 0.30 ng/mL/cc, 0.16 ng/mL/cc and 0.22 in patients with benign biopsies, respectively. ROC curves analysis demonstrated that PSATZ had a higher area under curve (0,838) than F/T ratio (0,806) (P<0.001) and PSAD (0,806) (P<0.001). With a cut-off value of 0.22 ng/mL/cc, PSATZ had 100% of sensitivity and could have prevented 24% of unnecessary biopsies.
Conclusions: PSATZ may be useful in enhancing the specificity of serum PSA. Compared to other PSA related parameters, it was better in differentiating between prostate cancer and benign prostatic enlargement. Also, PSATZ could reduce a significant number of unnecessary biopsies.
Keywords: Biopsy; Diagnosis; Prostate.
Copyright® by the International Brazilian Journal of Urology.
Conflict of interest statement
Conflict of interest: None declared.
Figures
Similar articles
-
Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer.Int J Urol. 1999 Sep;6(9):455-62. doi: 10.1046/j.1442-2042.1999.00089.x. Int J Urol. 1999. PMID: 10510891
-
PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.Ann Clin Lab Sci. 2003 Summer;33(3):320-3. Ann Clin Lab Sci. 2003. PMID: 12956448
-
Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases.Int J Urol. 2006 Jul;13(7):910-4. doi: 10.1111/j.1442-2042.2006.01439.x. Int J Urol. 2006. PMID: 16882054
-
[PSATZ (prostate specific antigen adjusted for the transition zone volume)].Nihon Rinsho. 1998 Aug;56(8):2016-20. Nihon Rinsho. 1998. PMID: 9750499 Review. Japanese.
-
[The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].Prog Urol. 1997 Jun;7(3):455-63. Prog Urol. 1997. PMID: 9273075 Review. French.
Cited by
-
Transition-zone PSA-density calculated from MRI deep learning prostate zonal segmentation model for prediction of clinically significant prostate cancer.Abdom Radiol (NY). 2024 Oct;49(10):3722-3734. doi: 10.1007/s00261-024-04301-z. Epub 2024 Jun 19. Abdom Radiol (NY). 2024. PMID: 38896250
-
Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis.Investig Clin Urol. 2022 May;63(3):251-261. doi: 10.4111/icu.20210429. Investig Clin Urol. 2022. PMID: 35534215 Free PMC article.
-
Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL.Front Oncol. 2022 Dec 5;12:1020317. doi: 10.3389/fonc.2022.1020317. eCollection 2022. Front Oncol. 2022. PMID: 36582803 Free PMC article.
-
The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer.PLoS One. 2019 Nov 19;14(11):e0218645. doi: 10.1371/journal.pone.0218645. eCollection 2019. PLoS One. 2019. PMID: 31743339 Free PMC article.
-
Artificial intelligence-assisted enhancement of prostate volume metrics in the diagnosis of clinically significant prostate cancer: a retrospective analysis.Quant Imaging Med Surg. 2025 Feb 1;15(2):1641-1652. doi: 10.21037/qims-24-1015. Epub 2025 Jan 16. Quant Imaging Med Surg. 2025. PMID: 39995717 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
-
- INCA Instituto Nacional de Câncer José Alencar Gomes da Silva . Coordenação de Prevenção e Vigilância. Estimativa 2014: Incidência de Câncer no Brasil [monography on internet] Rio de Janeiro: INCA; 2014. [[cited 2015 Oct 09]]. Available from: < www.saude.sp.gov.br/resources/ses/perfil/gestor/homepage/outros-destaque...>.
-
- Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 1995;154(2 Pt 1):407–413. - PubMed
-
- Sandblom G, Ladjevardi S, Garmo H, Varenhorst E. The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate. Cancer. 2008;112:813–819. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous